• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

177.7000 USD 0.5100 0.29%

As of 20:04:04 ET on 11/25/2014.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 179.0000 High - Low: 179.4656 - 175.9100 Primary Exchange: NYSE Arca
Volume: 284,248 52-Week Range: 115.3117 - 179.4656 Beta vs SPSIBITR: 1.0001

ETF Chart for XBI

No chart data available.
  • XBI:US 177.7000
  • 1D
  • 1M
  • 1Y
178.2100
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2014-11-25) 177.6397
Assets (M) (on 2014-11-25) 1,332.2980
Shares out (M) 7.50
Market Cap (M) 1,332.75
% Premium 0.03
Average 52-Week % Premium -0.0109
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.5628
Dividend Yield (ttm) 0.87%

Performance for XBI

1-Month +6.57% 1-Year +43.02%
3-Month +16.41% 3-Year +44.00%
Year To Date +37.82% 5-Year +29.16%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 11/24/2014
Name Position Value % of Total
Agios Pharmaceuticals Inc 342,430 33,126,678 2.514%
Receptos Inc 253,835 32,153,279 2.440%
Geron Corp 6,156,720 23,641,805 1.794%
Incyte Corp 310,927 23,487,426 1.782%
AMAG Pharmaceuticals Inc 593,104 21,642,365 1.642%
Celldex Therapeutics Inc 1,000,329 20,936,886 1.589%
PTC Therapeutics Inc 462,892 20,557,034 1.560%
Alnylam Pharmaceuticals Inc 208,745 20,077,094 1.523%
Anacor Pharmaceuticals Inc 611,923 19,918,094 1.511%
Dyax Corp 1,440,392 19,603,735 1.488%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil